EmtinB With Copaxone as Potential MS Therapy & CAR T-cell Therapy Shows Promise

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about a patent that has been filed in Australia for EmtinB in combination with Copaxone as a potential MS treatment.

He also reads about a new CAR T-cell therapy that eliminates the self-reactive immune cells that drive MS without destroying healthy immune cells.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/